MiMedx Group, Inc. (MDXG) CEO Tim Wright on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/09/21
MiMedx Announces Fourth Quarter and Full Year 2020 Financial and Operating ResultsGlobeNewsWire • 03/08/21
MiMedx to Host Fourth Quarter and Full Year 2020 Operating and Financial Results Conference Call on March 9GlobeNewsWire • 03/02/21
MiMedx to Participate at the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceGlobeNewsWire • 02/10/21
MiMedx: Raising Our PT To $31 On New Findings That Indicate Amniofix Will Be A Blockbuster, Game-Changing Osteoarthritis TreatmentSeeking Alpha • 12/16/20
MiMedx To Present at the Piper Sandler 32nd Annual Virtual Healthcare ConferenceGlobeNewsWire • 11/24/20
MiMedx To Host Virtual 2020 Annual Meeting of Shareholders on Friday, November 20GlobeNewsWire • 11/13/20
MiMedx Group, Inc. (MDXG) CEO Tim Wright on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/08/20
MiMedx Announces Largest U.S. Commercial Payor Will Provide Coverage for EpiFix in the Treatment of Diabetic Foot UlcersGlobeNewsWire • 11/03/20
MiMedx Concludes Enrollment for Phase 2B Study of Osteoarthritis (OA) of the KneeGlobeNewsWire • 09/21/20
MiMedx Launches EpiCord Expandable Placental Allograft as Addition to Market Leading PortfolioGlobeNewsWire • 09/14/20